1.74 USD
↗ 0.10 (6.10%)AT CLOSE (11:59 AM EDT)
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $1.69 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, NAUT appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 17, 2026.